Australian Prescriber

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

gabapentin

antiepileptic - Neurontin (New drug) 17(3) 73

in epilepsy 22(3) 61-3

Neurontin (New formulation) 23(5) 110-1

in neuropathic pain 22(6) 140-1

Nupentin (New brand) 27(5) 131-3

Pendine (New brand) 25(6) 147-51

promotion and off-label prescribing 26(1) 18-9

editorial comment 26(1) 19

letters 27(4) 82-3; 26(3) 51-2; 26(2) 27-9

Gabitril

see tiagabine 21(1) 25-7

gadobenate dimeglumine

MultiHance - magnetic resonance imaging - contrast agent (New drug) 27(6) 159-65

gadodiamide

MRI contrast medium - Omniscan (New drug) 17(2) 30-2

gadoteric acid

contrast medium - Dotarem (New drug) 25(6) 147-51

gadoteridol

contrast medium - Prohance (New drug) 25(2) 44-7

gadoversetamide

contrast medium - OptiMARK (New drug) 24(3) 71-5

gadoxetate disodium

Primovist - liver imaging (New drug) 29(3) 84-7

galantamine

Alzheimer's disease - Reminyl (New drug) 24(4) 100-2

Reminyl (New formulation) 27(4) 101-5

ganciclovir

Cymevene (New strength) 23(3) 64-7

new formulation - Cymevene 19(2) 38-40

valganciclovir - cytomegalovirus retinitis - Valcyte (New drug) 25(6) 147-51

ganirelix

assisted reproduction - Orgalutran (New drug) 24(6) 155-8

Gardasil - see human papillomavirus vaccine

gas exchange and transfer

respiratory function tests 23(1) 10-2

gastric mucosa

pharmacology of acid secretion inhibitors 23(3) 57-9

gastric ulcer

letter - barium meals vs endoscopy 19(3) 59-62

management 18(4) 97-9

pharmacology of acid secretion inhibitors 23(3) 57-9

gastroenteritis

oral rehydration in children (letter) 17(1) 4-5

rotavirus vaccine - Rotarix (New drug) 29(4) 112-5

rotavirus vaccine - RotaTeq (New drug) 29(4) 112-5

gastroenterology

Therapeutic Guidelines - book reviews 30(2) 46; 26(3) 58

gastrointestinal haemorrhage

aspirin and alcohol 28(1) 18-9

letter 28(4) 84-7

management 28(3) 62-6

letter 28(6) 136-9

paracetamol adverse effects (letter) 30(3) 59-63

gastrointestinal motility disorders

alternatives to cisapride 25(6) 135; 24(5) 110-2

gastrointestinal physiology

coeliac disease diagnosis (letter) 25(2) 27-8

in irritable bowel syndrome 24(3) 68-71

gastrointestinal stromal tumour

sunitinib - Sutent (New drug) 29(6) 167-71

gastro-oesophageal reflux disease

alendronate adverse effects in older patients (letter) 21(1) 5-8

cisapride alternatives 24(5) 110-2

cisapride interactions 25(6) 135; 23(3) 59

letter 23(5) 93-6

coeliac disease diagnosis (letter) 25(2) 27-8

esomeprazole - Nexium (New drug) 25(4) 94-9

lansoprazole - Zoton (New drug) 17(3) 73

management 18(4) 97-9

letter - barium meals vs. endoscopy 19(3) 59-62

pantoprazole - Somac (New drug) 19(1) 24-7

pharmacology of acid secretion inhibitors 23(3) 57-9

proton pump inhibitors

costs and benefits 20(1) 16

letter 20(3) 57-60

long-term management 31(1) 5-7

rabeprazole - Pariet (New drug) 24(2) 43-7

gastroparesis

alternatives to cisapride 25(6) 135; 24(5) 110-2

cisapride interactions (letters) 23(5) 93-6

gatifloxacin

antibiotic - Tequin (New drug) 24(3) 71-5

Gaucher's disease type I

alglucerase - Ceredase (New drug) 18(1) 4-7

imiglucerase - Cerezyme (New drug) 22(4) 95-8

gefitinib

lung cancer - Iressa (New drug) 26(4) 94-5

gelatin, succinylated

gemcitabine - non-small cell lung cancer - Gemzar (New drug) 19(3) 81-3

plasma volume substitute - Geofusine (New drug) 22(1) 20-3

gemcitabine

pancreatic carcinoma 28(2) 42-4

gemfibrozil

cerivastatin combination and rhabdomyolysis (letter) 24(5) 107-9

DBL Gemfibrozil (New brand) 23(2) 45-6

Gemzar

see gemcitabine 19(3) 81-3

general practice

in the 21st century (editorial) 23(1) 4

cognitive behaviour therapy 24(2) 33-7

diabetes intensive management 25(5) 102-3

letter 26(1) 3-4

doctor-patient relations 21(4) 92-4

letter 22(2) 28-31

drugs for the doctor's bag 30(6) 143-6; 19(4) 89-92

electronic prescribing (editorial) 23(3) 50-1

letter 24(4) 80-2; 23(5) 93-6

emergency management of dental pain 24(6) 144-8

General Practice Series - CD review 25(3) 56

management of heavy drinkers 25(3) 70-3

thiamine deficiency (letter) 25(5) 104-7

management of mild depression 28(1) 8-10

National Prescribing Service (editorial) 21(2) 30-1

online information services 27(1) 16-8

prescriber feedback (editorials) 21(1) 2-3

prescribing and the law (editorial) 27(5) 108-9

letters 28(2) 29-33

psychotropic drugs for children and adolescents 28(5) 116-8

smoking cessation guidelines 28(3) 73-5

letter 28(6) 136-9

generic drugs

bioavailability (PBAC question) 23(5) 99

bioequivalence 26(4) 85-7

and drug regulation 26(4) 85-7

letters 26(6) 124-5

and pharmacokinetics 30(2) 41-3

letters 30(4) 88-90

brand price premiums (PBAC question) 23(2) 32

patent evergreening (editorial) 29(6) 148-9

Pharmaceutical Benefits Scheme drug price reforms (editorial) 30(6) 138-40

pitfalls of prescribing generics (letter) 28(4) 84-7

quality use (editorial) 27(4) 80-1

letters 28(2) 29-33; 27(6) 138-41

generic prescribing

prescription errors (letter) 17(4) 79-81

genetic disorders

DNA tests - approach and techniques 18(2) 45-8

DNA tests - clinical applications 18(3) 76-9

letter - test for von Hippel Lindau syndrome 19(1) 3-6

gene therapy 20(3) 72-3

genetics

glossary of molecular genetics terminology 21(3) 69-71

genital warts

imiquimod - Aldara (New drug) 22(1) 20-3

GenRx cefaclor CD

see cefaclor 24(1) 20-3

GenRx ipratropium

see ipratropium 24(1) 20-3

Geofusine

see succinylated gelatin 22(1) 20-3

geriatric - see aged

gestodene

risk of thromboembolism 25(3) 57-9

gestodene/ethinyloestradiol combination

oral contraceptive - Femoden, Trioden, Minulet, Triminulet (New drug) 18(1) 7-9

gestrinone

corticosteroids 21(1) 11-4

endometriosis - Dimetriose (New drug) 19(1) 24-7

gingival enlargement

drug-induced 29(6) 154-5; 26(1) 11-3

gingival hyperplasia and nifedipine

letter 17(1) 4-5

gingivitis

and diabetes 27(2) 36-8

Ginkgo biloba

efficacy in tinnitus (editorial) 29(5) 120

letter 30(2) 32-4

Glamin

see amino acid dipeptide 25(4) 94-9

glatiramer

Copaxone (New formulation) 27(5) 131-3

in multiple sclerosis 25(2) 32-5

multiple sclerosis - Copaxone (New drug) 22(6) 147-51

glaucoma

apraclonidine - Iopidine (New drug) 18(3) 58-9

bimatoprost - Lumigan (New drug) 26(1) 22-3

brimonidine - Alphagan (New drug) 22(2) 43-7

brinzolamide - Azopt (New drug) 24(2) 43-7

dorzolamide - Trusopt Eye Drops (New drug) 20(2) 45-51

drug treatment 25(6) 142-6

latanoprost - Xalatan (New drug) 21(2) 49-55

levobunolol - Betagan (New drug) 17(4) 87-90

patient support organisations 25(6) 146

travoprost - Travatan (New drug) 25(3) 74-5

gliclazide

Diamicron (New formulation) 24(6) 155-8

Glyade (New brand) 23(2) 45-6

Nidem (New brand) 24(6) 155-8

glimepiride

type 2 diabetes - Amaryl (New drug) 24(3) 71-5

glipizide

Melizide (New brand) 17(2) 30-2

glitazones

see thiazolidinediones 27(3) 67-70; 27(3) 70-4

Glivec

see imatinib 24(5) 129-31

glomerular filtration rate

abnormal laboratory results 24(1) 15-7

drug dosage adjustment in kidney disease 30(1) 17-20

letter 30(2) 32-4

gloves

in dentistry and medicine - latex allergy - letter 18(1) 4-7

glucagon

vs glucose 50% in doctor's bag supplies (PBAC question) 20(2) 33-4

Glucobay

see acarbose 21(2) 49-55

glucocorticoids

in croup 20(4) 99-101

doctor's bag supplies for asthma (letter) 20(2) 31-2

pharmacology 19(2) 41-4

glucosamine

and osteoarthritis (PBAC question) 28(2) 48

in osteoarthritis of the knee 27(3) 61-3

letter 27(5) 109-13

glucose 50%

vs glucagon in doctor's bag supplies (PBAC question) 20(2) 33-4

gluten enteropathy

diagnostic tests 24(2) 38-40

patient support organisations 24(2) 40-1

Glyade

see gliclazide 23(2) 45-6

glyceryl trinitrate

in early management of myocardial infarction 19(2) 52-4

prescription costs (PBAC question) 18(1) 12

glycoprotein IIb/IIIa receptor antagonists

warfarin interactions 25(4) 81-5

goitre

iodine in herbal cough mixture (letter) 24(3) 51-5

management 17(3) 70-2

gold injections

in adult rheumatoid arthritis 26(2) 36-40

Gonal-F

see follicle stimulating hormone 21(2) 49-55

see follitropin alfa 26(5) 118-9; 25(4) 94-9

gonorrhoea

abnormal laboratory results 30(1) 8-13

enoxacin - Enoxicin (New drug) 18(1) 7-9

Gopten

see trandolapril 27(6) 159-65

goserelin

in prostate cancer 19(1) 22-4

gout

azathioprine - allopurinol interactions 22(1) 19

management 27(1) 10-3

letter 27(4) 82-3

granisetron

Kytril - nausea and vomiting (New drug) 27(4) 101-5

Granocyte

see lenograstim 25(4) 94-9; 17(2) 30-2

granulocyte colony stimulating factor

ancestim combination therapy in breast cancer (New drug) 23(6) 137-9

letter 24(2) 27-8

lenograstim - neutropenia - Granocyte (New drug) 17(2) 30-2

pegfilgrastim - neutropenia - Neulasta (New drug) 25(6) 147-51

grapefruit juice

drug interactions 25(2) 37

grepafloxacin

antibiotic - Raxar (New drug) 22(5) 125-7

griseofulvin

in cutaneous fungal infections 19(3) 72-5

growth hormone inhibitors

lanreotide - acromegaly - Somatuline LA (New drug) 25(2) 44-7

guanethidine

regional sympathetic block - Ismelin (New drug) 17(3) 73

guarana

caffeine content (letter) 21(1) 5-8

complementary medicines safety (editorial) 25(3) 50-1

guidelines (see also therapeutic guidelines)

turning knowledge into action (editorial) 30(5) 114-5

gum disease - see periodontitis

gynaecomastia and disodium pamidronate

letter 22(2) 28-31

Gynazole - see butoconazole nitrate

Home

Useful Links

Privacy

Web Manager



	Home About Us Contact Us Index Search Consumer Topics Back Issues